Dermatologists
3 years of experience

Accepting new patients
West Vallejo
2290 Sacramento St
Vallejo, CA 94590
707-399-4500
Locations and availability (4)

Education ?

Medical School Score Rankings
Stanford University (2007)
  • Currently 4 of 4 apples
Top 25%

Awards & Distinctions ?

Associations
American Society for Dermatologic Surgery

Affiliations ?

Dr. Spanogle is affiliated with 2 hospitals.

Hospital Affilations

Score

Rankings

  • Sarasota Memorial Hospital
    1700 S Tamiami Trl, Sarasota, FL 34239
    • Currently 4 of 4 crosses
    Top 25%
  • Fairmont Medical Center
    PO Box 835, Fairmont, MN 56031
    • Currently 2 of 4 crosses
  • Publications & Research

    Dr. Spanogle has contributed to 5 publications.
    Title Risk of Second Primary Malignancies Following Cutaneous Melanoma Diagnosis: a Population-based Study.
    Date May 2010
    Journal Journal of the American Academy of Dermatology
    Excerpt

    Understanding risk patterns for developing a second primary malignancy (SPM) after cutaneous melanoma (CM) has implications for both research and clinical practice, including cancer screening.

    Title Comparison of Vegf-producing Cells in Periprosthetic Osteolysis.
    Date October 2006
    Journal Biomaterials
    Excerpt

    The pro-angiogenic cytokine vascular endothelial growth factor (VEGF) has been implicated in periprosthetic osteolysis and subsequent aseptic loosening of implants following total hip arthroplasty (THA). The goal of this study was to investigate whether increased VEGF at the bone-implant interface is secondary to a greater number of VEGF-producing cells or to increased VEGF production by individual cells. Real time polymerase chain reaction (RT-PCR) techniques were used to assess the expression of VEGF mRNA (isoforms 121, 165, 189) in periprosthetic tissues from revision THAs. Immunofluorescence was used to determine both differences in overall cellularity and in VEGF-producing cell type (macrophages, fibroblasts, endothelial cells) between patients with periprosthetic osteolysis (OL) and a control group undergoing primary THA for osteoarthritis (OA). Quantitative analysis of VEGF release in periprosthetic membranes via RT-PCR demonstrated no significant difference in the per-cell mRNA production of VEGF isoforms 121 165, or 189 between OL and OA patient groups. Immunofluorescence showed both higher cellularity and higher overall VEGF expression in the OL group. Immunofluorescence also showed a significant increase in macrophages in the OL group, but no significant difference in the proportion of fibroblasts or endothelial cells between the OL and OA groups. Co-localization of CD68+ and CD11b+ macrophage fluorescent signals with VEGF signal was greater in the OL group than in the OA group. Our results demonstrate that increased VEGF in OL periprosthetic tissue compared to OA synovium is correlated to increased numbers of VEGF-producing CD68+ and CD11b+ macrophages. Impact statement: Aseptic loosening, caused in large part by OL, remains the major cause of failed THAs leading to revision surgery. At the bone-implant interface, we found increased numbers of macrophages-cellular mediators of OL-and increased VEGF expression. VEGF may be a possible target for therapeutic intervention in mitigating OL.

    Title Successes and Failures of Hospital Ethics Committees: a National Survey of Ethics Committee Chairs.
    Date April 2002
    Journal Cambridge Quarterly of Healthcare Ethics : Cq : the International Journal of Healthcare Ethics Committees
    Title A National Study of Ethics Committees.
    Date April 2002
    Journal The American Journal of Bioethics : Ajob
    Excerpt

    Conceived as a solution to clinical dilemmas, and now required by organizations for hospital accreditation, ethics committees have been subject only to small-scale studies. The wide use of ethics committees and the diverse roles they have played compel study. In 1999 the University of Pennsylvania Ethics Committee Research Group (ECRG) completed the first national survey of the presence, composition, and activities of U.S. healthcare ethics committees (HECs). Ethics committees are relatively young, on average seven years in operation. Eighty-six percent of ethics committees report that they played a role in ongoing clinical decision making through clinical ethics consultation. All are engaged in developing institutional clinical policy. Although 4.5% of HECs write policy on managed care, 50% of HEC chairs feel inadequately prepared to address managed care. The power and activity of ethics committees parallels the composition of those committees and the relationship of members to their institutions. The role of ethics committees across the nation in making policies about clinical care is greater than was known, and ethics committees will likely continue to play an important role in the debate and resolution of clinical cases and clinical policies.

    Title Healthcare Ethics Committees and Managed Care.
    Date October 2001
    Journal The American Journal of Managed Care
    Excerpt

    Healthcare ethics committees (HECs) play an important role in medical decision making in US hospitals, but no study has determined whether HECs deal with managed care, in any form. This pilot study was performed to evaluate the activities and perceptions of HECs about managed care.


    Similar doctors nearby

    Dr. John Geisse

    Dermatology
    25 years experience
    Vallejo, CA

    Dr. Serena Mraz

    Dermatology
    17 years experience
    Vallejo, CA

    Dr. Eileen Crowley

    Anesthesiology
    13 years experience
    Vallejo, CA

    Dr. Paradi Mirmirani

    Dermatology
    16 years experience
    Vallejo, CA

    Dr. Robin Gray

    Dermatology
    12 years experience
    Vallejo, CA

    Dr. Jennifer Krasnoff

    Dermatology
    18 years experience
    Hercules, CA
    Search All Similar Doctors